What's Happening?
Kate Tolo, girlfriend and business partner of biohacker Bryan Johnson, is using a $15,700 "research grade erection device" to track her nighttime vaginal blood flow. This device, which she refers to as a "techno tampon," is inserted nightly to measure
changes in blood flow to the clitoris. Tolo aims to revive research from over 40 years ago that explored the potential of tracking female nocturnal erections to gain insights into women's health, including sexual dysfunction and early signs of heart issues. The technology, originally invented in 1975, has seen little improvement or published research in the past five decades. Tolo's setup involves a 5cm probe, a wire taped to her leg connected to a machine, and a laptop that must remain active to avoid data loss. This contrasts with Johnson's male erection tracker, which costs $275 and connects to a smartphone, highlighting a significant disparity in the accessibility and cost of health tracking devices for different sexes.
Why It's Important?
This initiative is important because it highlights a significant gap in women's health research and technology. While male nocturnal erections have been studied as a predictor of longevity and vascular health, similar research for women has largely been neglected. Tolo's efforts could potentially pave the way for new diagnostic tools for female sexual dysfunction, helping to differentiate between physical and psychological causes. Furthermore, if tracking vaginal blood flow proves to be an early indicator of cardiovascular disease in women, similar to how erectile dysfunction serves this purpose in men, it could lead to earlier detection and intervention for the leading cause of death for both sexes. The high cost and cumbersome nature of Tolo's device also underscore the need for more accessible and user-friendly health monitoring solutions tailored to women's unique physiological needs, potentially spurring innovation in this underserved area of medical technology.
What's Next?
Kate Tolo plans to continue her research, having already created "the female protocol" to measure 1,900 biomarkers across various bodily fluids while maintaining consistent diet, sleep, and exercise. Her ongoing efforts aim to publicly publish data on female nocturnal erections, which her partner Bryan Johnson notes is the first serious attempt to do so. The goal is to generate new insights into female health that have been overlooked for decades. If Tolo's research yields significant findings, it could encourage further scientific investigation into the correlation between nocturnal vaginal blood flow and overall health, potentially leading to the development of more affordable and practical devices for women. This could also prompt a broader discussion within the medical community about the historical underrepresentation of women in health research and the need for more equitable scientific inquiry.
Beyond the Headlines
Beyond the immediate health implications, this story touches on deeper societal and ethical considerations regarding gender disparities in scientific research and technological development. The stark contrast between the cost and convenience of male versus female health tracking devices, as highlighted by Johnson, reflects a systemic bias where male physiology has often been the default subject of study. Tolo's personal investment in this research, despite the significant financial and practical hurdles, underscores a broader movement among individuals to take control of their health data and advocate for more inclusive scientific exploration. This biohacking approach, while unconventional, challenges traditional research paradigms and could inspire a more patient-centric model of health discovery, where individuals actively contribute to and shape the understanding of their own bodies. It also raises questions about the commercialization of health data and the potential for personalized medicine to address long-standing gender inequities in healthcare.
